Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.2920
+0.0068 (2.38%)
At close: Jul 3, 2025, 1:00 PM
0.2948
+0.0028 (0.96%)
After-hours: Jul 3, 2025, 4:59 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $14.28 million as of July 3, 2025. Its market cap has decreased by -85.44% in one year.
Market Cap
14.28M
Enterprise Value
19.70M
1-Year Change
-85.44%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $14.28M, a decrease of -95.92%. That is a compound annual growth rate of -62.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 13.95M | -84.38% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.55B |
| Johnson & Johnson | 375.15B |
| AbbVie | 335.60B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 295.85B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 237.07B |
| AstraZeneca | 221.10B |